Owen Mumford, a medical device manufacturer and certified B Corp, has had its near-term emissions reduction target approved by the Science Based Targets initiative (SBTi).
The company has also committed to set long-term emissions reduction targets with the SBTi in line with reaching net-zero by 2045 – 5 years ahead of the UK’s net-zero target.
The SBTi, a collaboration established to support companies with their sustainability goals using a global framework, has validated Owen Mumford’s scope 1 and 2 near-term targets – beginning with 2030. This validation confirms that its targets align with a trajectory aimed at limiting global warming to 1.5°C, in accordance with the goals of the 2015 Paris Agreement.
By developing standards, tools and guidance, the SBTi enables businesses to set ambitious greenhouse gas emissions reduction targets aligned with the latest scientific research. These targets are essential for mitigating the impacts of climate change and working towards achieving net-zero emissions by 2050.
As a manufacturer and distributor of mostly single-use medical devices, the company has taken a holistic approach to sustainability, evaluating operations and processes across its entire network, including the introduction of a bespoke lifecycle assessment technology platform to measure the impact of its devices’ lifecycle and identify improvements.
Confirmed Near-Term and Net-Zero Targets:
- Reaching net-zero greenhouse gas emissions across the value chain by FY2045
- Reduce absolute scope 1, 2 and 3 GHG emissions 42% by FY2030 from a FY2022 base year
Long-Term Targets:
- Reduce absolute scope 1, 2 and 3 GHG emissions to net zero by FY2045 from a FY2022 base year
“By establishing and working towards scientifically measured emissions reduction targets, we not only contribute to global initiatives combating climate change but also uphold our commitment to our customers and the rigorous standards we set for ourselves.” Said Paul Smith, Group Quality & Regulatory Affairs Director and Executive responsible for Sustainability at Owen Mumford.